Translation from cryptic reading frames of DNA vaccines generates an extended repertoire of immunogenic, MHC class I-restricted epitopes

被引:27
作者
Schirmbeck, R
Riedl, P
Fissolo, N
Lemonnier, FA
Bertoletti, A
Reimann, J
机构
[1] Univ Ulm, Inst Med Microbiol & Immunol, D-89081 Ulm, Germany
[2] Inst Pasteur, Unite Immunite Cellulaire, Dept Immunol, Paris, France
[3] UCL, Inst Hepatol, London, England
关键词
D O I
10.4049/jimmunol.174.8.4647
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To test whether simple expression units used in DNA vaccines can generate immunogenic, MHC class I-binding epitopes by translating other than the primary open reading frame (ORF), we constructed a vector (pCI/SX) that encodes the small hepatitis B surface Ag in the primary ORF, and a C-terminal fragment (residue 344-832) of the polymerase (Pol) in an alternative (out-of-frame) reading frame. pCI/SX efficiently primed multispecific, HLA-A2-restricted CD8(+) T cell responses to epitopies of hepatitis B surface Ag and of Pol (Pol3, Pol(803-811)). Pol3-containing products generated from pCI/SX were detected only by T cell assays, but not by biochemical assays. Priming Pol-specific T cell responses to epitopes generated from alternative ORFs depended on promoter sequences that drive transcription in the DNA vaccine (human CMV-derived promoter sequences being more efficient than SV40-derived promoter sequences). Human CMV promoter-driven Pol constructs encoding different Pol fragments in primary or alternative reading frames elicited comparable levels of Pol3-specific T cell responses. We confirmed efficient T cell priming to epitopes from alternative ORFs by constructing DNA vaccines that encode an SV40-derived cT(1-272) protein fused either in frame or out of frame with an immunogenic OVA fragment (OVA(18-385)). Similar.OVA-specific CD8(+) T cell responses were primed by both alternative vaccine constructs. Hence, DNA vaccine-stimulated T cell responses to epitopes generated from alternative ORFs seem to be a regular event, although its biological role and risks are largely unexplored.
引用
收藏
页码:4647 / 4656
页数:10
相关论文
共 34 条
[11]   Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: Implications for immunotherapy of persistent viral infections [J].
Kakimi, K ;
Isogawa, M ;
Chung, JS ;
Sette, A ;
Chisari, FV .
JOURNAL OF VIROLOGY, 2002, 76 (17) :8609-8620
[12]  
KUHROBER A, 1996, J IMMUNOL, V156, P3687
[13]   Polyvalent DNA vaccines with bidirectional promoters [J].
Kwissa, M ;
Unsinger, J ;
Schirmbeck, R ;
Hauser, H ;
Reimann, J .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2000, 78 (09) :495-506
[14]   Multiepitopic HLA-A*0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization [J].
Loirat, D ;
Lemonnier, FA ;
Michel, ML .
JOURNAL OF IMMUNOLOGY, 2000, 165 (08) :4748-4755
[15]   Non-traditionally derived CTL epitopes: exceptions that prove the rules? [J].
Mayrand, SM ;
Green, WR .
IMMUNOLOGY TODAY, 1998, 19 (12) :551-556
[16]  
Mayrand SM, 1998, J IMMUNOL, V160, P39
[17]   Regulatory elements of hepatitis B virus transcription [J].
Moolla, N ;
Kew, M ;
Arbuthnot, P .
JOURNAL OF VIRAL HEPATITIS, 2002, 9 (05) :323-331
[18]   DELETIONS IN THE HEPATITIS-B VIRUS SMALL ENVELOPE PROTEIN - EFFECT ON ASSEMBLY AND SECRETION OF SURFACE-ANTIGEN PARTICLES [J].
PRANGE, R ;
NAGEL, R ;
STREECK, RE .
JOURNAL OF VIROLOGY, 1992, 66 (10) :5832-5841
[19]   Properties of monoclonal antibodies directed against hepatitis B virus polymerase protein [J].
Putlitz, JZ ;
Lanford, RE ;
Carlson, RI ;
Notvall, L ;
De la Monte, SM ;
Wands, JR .
JOURNAL OF VIROLOGY, 1999, 73 (05) :4188-4196
[20]   Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection [J].
Rehermann, B ;
Lau, D ;
Hoofnagle, JH ;
Chisari, FV .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) :1655-1665